248 Myeloid Derived Suppressor Cells (MDSC)-like Acute Myeloid Leukemia (AML) Cells Are Associated with Resistance to Cytotoxic Effects of Autologous (Auto) T-Lymphocytes (CTLs)

Track: Poster Abstracts
Wednesday, February 11, 2015, 6:45 PM-7:45 PM
Grand Hall CD (Manchester Grand Hyatt)
Rohtesh S Mehta, MD MPH MS , Stem Cell Transplant and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
Xiaohua Chen, Ph.D MD , Pediatrics/Blood and Marrow Transplantation and Cellular Therapy, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
Jeyaraj Antony, Ph.D , Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
Paul Szabolcs, MD , Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
Presentation recording not available for download or distribution as requested by the presenting author.

Background: Ex-vivo expansion of CBT-cells using CD3/CD28 co-stimulatory beads, IL-2 + IL-7 & subsequent priming against leukemia cell lines using IL-15 generated specific CTLs. [1, 2] Using similar immune-stimulatory culture conditions, we generated auto PB-derived CTLs from AML patients in 5 of 8 samples. [Abstract #5836] The aim of present study was to find source of disparity between “resistant” (n=3) & non-resistant AML (n=5).

Hypothesis: We hypothesized (a) in contrast to AML cells that are susceptible to cytotoxicity by auto CTLs (n=5), the “resistant” AML cells (n=3), would possess features similar to myeloid-derived suppressor cells (MDSCs). 

Methods: AML blasts were purified from PBMCs of AML patients admitted with blast crisis (n=8). AML-specific auto CTLs were generated using immune-stimulatory culture conditions as described. [Abstract #5836] RNA purification & RT-qPCR from blasts was done using Trizol reagent (Life Technologies) & Power SYBR® Green master mix (Applied Biosystems) with StepOne Plus system (Life Technologies) as suggested by manufacturers. Genes with defined role in MDSC generation [2] were selected for analysis. Primers were designed using NCBI primer blast. [3] GAPDH was used as house-keeping gene. Student t-test was used to compare the groups.

Results: Resistant blasts had significant up-regulation of JAK-2, S100A8, S100A9 and c-myc compared to the susceptible blasts. [Table 1]  Although JAK-1 and JAK-3 were up-regulated notably, statistical significance was not met.

Discussion: JAK-2 signaling pathway is critical for MDSC generation and survival, which induces c-myc expression, while S100A8 & S100A9 potentiate the suppressive effects of MDSC. [Figure 1] [2] Many solid tumors assume MDSC-like phenotype, [2] but this is rarely reported in hematological malignancies. [3, 4] Our findings mandate further validation. If replicated, therapeutic roles of JAK and S100 pathway inhibitors could be explored.

 

Figure 1: Signalling pathways involved in the expansion of mDSCs [2]

(reproduced with written permission from the Nature Publishing Group)

Refs:

1.    Jeyaraj A et al. IL-15 Induced Polyclonal CTL Generated From Expanded CBT Cells Against Leukemia Cell Lines Constitutes IFN-γ Producing Cells and TCRγd Cells. ASH 2012 Annual Meeting

2.       Gabrilovich DI et al. Nat Rev Immunol. (2009) Myeloid-derived suppressor cells as regulators of the immune system.

3.       Primer BLAST http://www.ncbi.nlm.nih.gov/tools/primer-blast/

4.       Alex  AA et al. Myeloid Derived Suppressor Cells in Acute Leukemia and Its Association with Conventional Cytogenetic and Molecular Risk Factors. ASH 2010 Annual Meeting; 1446.

5.       Miner S et al. Myeloid Leukemias Directly Suppress T Cell Proliferation Through STAT3 and Arginase Pathways. Blood Nov 15, 2013; 122 (21)

Disclosures:
Nothing To Disclose
See more of: Poster Session 1: Leukemia
See more of: Poster Abstracts